Leading specialty therapy drugs in the U.S. by PMPY spending 2016

This statistic shows the leading specialty therapeutic drugs in the United States in 2016, based on per-member-per-year spending. Humira Pen (adalimumab) for inflammatory conditions had the highest PMPY spending, reaching over 45 U.S. dollars in that year.

Top 10 specialty therapy drugs in the U.S. by per-member-per-year (PMPY) spending in 2016 (in U.S. dollars)*

PMPY spending in U.S. dollars
Humira Pen (adalimumab)45.11
Enbrel (etanercept)26.82
Tecfidera (dimethyl fumarate)13.49
Copaxone (glatiramer)12.42
Harvoni (ledipasvir/sofosbuvir)9.86
Revlimid (lenalidomide)9.78
Gilenya (fingolimod)8.48
Truvada (emtricitabine/tenofovir disoproxil fumarate)8.44
Humira (adalimumab)8.15
Stelara (ustekinumab)8.13
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

2016

Supplementary notes

* The statistic includes members with commercial insurance coverage. Members used Express Scripts for retail and home delivery pharmacy services; they used Accredo, the Express Scripts specialty pharmacy, for specialty drug prescriptions.
PMPY metrics are calculated by dividing totals by the total number of member-months, which is determined by adding the number of months of eligibility for all members in the sample.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.